Merck ($MRK) Insider Trading & Smart Money Activity
Merck & Co., Inc. ($MRK) has 3 insider trades, 3 congress trades, 44 13F position changes and 6 analyst ratings on file. Insiders filed 3 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 3
- 13F moves on file
- 44
- Analyst ratings on file
- 6
MRK insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 1 | 1 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 10 / 14 |
| Q3 2026 | 0 | 0 | 1 / 1 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 5 / 14 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All MRK insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | SteelPeak Wealth | Reduced | -87.67K sh | $12.07M | — | ||||||
| 13F | Smead Capital Management | Reduced | -28.55K sh | $335.07M | — | ||||||
| 13F | Hengehold Capital Management | Reduced | -9.80K sh | $5.47M | — | ||||||
| 13F | DiNuzzo Private Wealth | Added | +200 sh | $164.20K | — | ||||||
| 13F | Cardinal Capital Management | Reduced | -2.35K sh | $29.66M | — | ||||||
| 13F | Cantor Fitzgerald Investment Advisors L.P. | Reduced | -73.10K sh | $5.51M | — | ||||||
| 13F | Birch Hill Investment Advisors | Reduced | -8.04K sh | $11.61M | — | ||||||
| 13F | Banque Pictet & Cie | Reduced | -95.03K sh | $59.34M | — | ||||||
| 13F | V-Square Quantitative Management | Added | +2.66K sh | $7.11M | — | ||||||
| 13F | Hbw Advisory Services | Reduced | -8.58K sh | $2.68M | Read | ||||||
| 13F | Guyasuta Investment Advisors | Reduced | -4.45K sh | $8.90M | — | ||||||
| 13F | Goldstein Advisors | Added | +1.82K sh | $909.35K | Read | ||||||
| 13F | Fort Washington Investment Advisors | Reduced | -247.58K sh | $60.94M | Read | ||||||
| 13F | Fjarde Ap-Fonden /Fourth Swedish National Pension Fund | Reduced | -161.39K sh | $158.53M | — | ||||||
| 13F | Community Trust & Investment | Reduced | -3.75K sh | $4.43M | — | ||||||
| 13F | Auto-Owners Insurance | Added | +121 sh | $1.08M | — | ||||||
| 13F | Moody Lynn Lieberson & Walker | Added | +18.52K sh | $18.75M | — | ||||||
| 13F | Godsey & Gibb | Reduced | -7.85K sh | $31.54M | — | ||||||
| 13F | Fulton Bank, N.A. | Reduced | -9.63K sh | $10.23M | — | ||||||
| Analyst | Morgan Stanley | Reiterates to Overweight | PT $177 | +3.2% | — | ||||||
| Analyst | JP Morgan | Reiterates to Overweight | PT $165 | +4.2% | — | ||||||
| Analyst | Scotiabank | Reiterates to Sector Outperform | PT $180 | -4.9% | — | ||||||
| Congress | Maria Elvira Salazar | Sale | $1,001 - $15,000 | -2.8% | Read | ||||||
| Congress | Maria Elvira Salazar | Purchase | $15,001 - $50,000 | +0.6% | -2.9% | — | |||||
| Analyst | Scotiabank | Reiterates to buy | PT $155 | +0.3% | +1.0% | Read | |||||
| Insider | Christine Seidman | Buy (Grant or award) | 63 sh | $8.10K | +0.3% | +1.0% | Read | ||||
| Insider | Karsanbhai Surendralal Lanca | Buy (Grant or award) | 127 sh | $16.32K | +0.3% | +1.0% | Read | ||||
| Insider | Coe Mary Ellen | Buy (Grant or award) | 234 sh | $30.07K | +0.3% | +1.0% | Read | ||||
| Analyst | B of A Securities | Reiterates to buy | PT $141 | +0.3% | +1.0% | Read | |||||
| Analyst | CICC | Reiterates to buy | PT $138 | +4.0% | +8.7% | Read | |||||
| 13F | Harris Associates L P | Reduced | -1.72M sh | $1.49B | +9.9% | +3.9% | — | ||||
| 13F | Harris Associates L P | Reduced | -1.72M sh | $1.59B | +9.9% | +3.9% | — | ||||
| 13F | Farallon Capital Management | New | +361K sh | $46.45M | +9.9% | +3.9% | — | ||||
| 13F | Brandes Investment Partners | Reduced | -164.96K sh | $295.88M | +9.9% | +3.9% | Read | ||||
| 13F | Aristotle Capital Management | Reduced | -386.46K sh | $832.57M | +9.9% | +3.9% | — | ||||
| 13F | Aristotle Capital Management | Reduced | -386.46K sh | $885.93M | +9.9% | +3.9% | Read | ||||
| Congress | Alan Armstrong | Sale | $15,001 - $50,000 | +1.0% | -7.9% | +26.0% | — |
Showing 37 of 56 filings (the latest 13F moves are capped at 25; see the institutions below).
1W / 1M / 6M = how MRK moved from the trade or filing date.
Insider trading in MRK: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Christine Seidman | 1 | — | Jun 30, 2026 | ||
| Karsanbhai Surendralal Lanca | 1 | — | Jun 30, 2026 | ||
| Coe Mary Ellen | 1 | — | Jun 30, 2026 |
Members of Congress trading MRK
Institutions moving MRK (13F)
- Fort Washington Investment Advisors2
- Harris Associates L P2
- Aristotle Capital Management2
- Caisse de Depot Et Placement Du Quebec2
- Korea Investment2
- Barrow Hanley Mewhinney & Strauss2
- Rakuten Investment Management2
- Jennison Associates2
- Royal London Asset Management2
- Swedbank2
- SteelPeak Wealth1
- Smead Capital Management1
Analyst ratings on MRK
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | Reiterates | Overweight | $179 → $177 | +3.2% | — | |||
| JP Morgan | Reiterates | Overweight | $150 → $165 | +4.2% | — | |||
| Scotiabank | Reiterates | Sector Outperform | $155 → $180 | -4.9% | — | |||
| Scotiabank | Reiterates | buy | $155 | +0.3% | +1.0% | Read | ||
| B of A Securities | Reiterates | buy | $141 | +0.3% | +1.0% | Read | ||
| CICC | Reiterates | buy | $138 | +4.0% | +8.7% | Read |
Frequently asked questions
What is the latest insider trade in MRK?
Christine Seidman filed a buy (grant or award) of 63 sh worth $8.10K on Jun 30, 2026.
Which members of Congress traded MRK?
3 disclosed trades by Maria Elvira Salazar and Alan Armstrong. The latest was on Sep 24, 2026.
Which institutions changed their MRK positions?
Recent 13F filers moving the stock include Fort Washington Investment Advisors, Harris Associates L P, Aristotle Capital Management, Caisse de Depot Et Placement Du Quebec and Korea Investment.
Other drug manufacturers - general stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.